168 related articles for article (PubMed ID: 38338778)
21. Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer.
Möller K; Fraune C; Blessin NC; Lennartz M; Kluth M; Hube-Magg C; Lindhorst L; Dahlem R; Fisch M; Eichenauer T; Riechardt S; Simon R; Sauter G; Büscheck F; Höppner W; Matthies C; Doh O; Krech T; Marx AH; Zecha H; Rink M; Steurer S; Clauditz TS
Int Urol Nephrol; 2021 Dec; 53(12):2493-2503. PubMed ID: 33797012
[TBL] [Abstract][Full Text] [Related]
22. Combined Immunohistochemistry for the "Three 7" Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution.
Zhou J; Yang X; Zhou L; Zhang P; Wang C
Dis Markers; 2019; 2019():4708154. PubMed ID: 31737127
[TBL] [Abstract][Full Text] [Related]
23. Alamandine via MrgD receptor attenuates pulmonary fibrosis via NOX4 and autophagy pathway.
Liu Q; Zheng B; Zhang Y; Huang W; Hong Q; Meng Y
Can J Physiol Pharmacol; 2021 Sep; 99(9):885-893. PubMed ID: 33517849
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of caveolin-1 in renal neoplasms.
Tamaskar I; Choueiri TK; Sercia L; Rini B; Bukowski R; Zhou M
Cancer; 2007 Aug; 110(4):776-82. PubMed ID: 17594718
[TBL] [Abstract][Full Text] [Related]
25. Alamandine: a new member of the angiotensin family.
Villela DC; Passos-Silva DG; Santos RA
Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):130-4. PubMed ID: 24389733
[TBL] [Abstract][Full Text] [Related]
26. Decarboxylation of Ang-(1-7) to Ala
Tetzner A; Naughton M; Gebolys K; Eichhorst J; Sala E; Villacañas Ó; Walther T
Eur J Pharmacol; 2018 Aug; 833():116-123. PubMed ID: 29792841
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical study of c-KIT (CD117) expression in renal cell carcinoma.
Ahmed EA; Youssif ME
J Egypt Natl Canc Inst; 2009 Jun; 21(2):121-32. PubMed ID: 21057563
[TBL] [Abstract][Full Text] [Related]
28. A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data.
Zhao H; Leppert JT; Peehl DM
PLoS One; 2016; 11(1):e0146505. PubMed ID: 26814892
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of subtypes of renal cell carcinoma with contrast-enhanced ultrasonography.
Xue LY; Lu Q; Huang BJ; Li CX; Yan LX; Wang WP
Clin Hemorheol Microcirc; 2016 Oct; 63(4):361-371. PubMed ID: 26598999
[TBL] [Abstract][Full Text] [Related]
30. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
31. Targeting glycolysis with 2-deoxy-D-glucose sensitizes primary cell cultures of renal cell carcinoma to tyrosine kinase inhibitors.
Simon AG; Esser LK; Ellinger J; Branchi V; Tolkach Y; Müller S; Ritter M; Kristiansen G; Muders MH; Mayr T; Toma MI
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2255-2265. PubMed ID: 32533404
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular Pathophysiology.
Hrenak J; Paulis L; Simko F
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27447621
[TBL] [Abstract][Full Text] [Related]
34. Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas.
Zhang Q; Liu JH; Liu JL; Qi CT; Yan L; Chen Y; Yu Q
BMC Cancer; 2019 Nov; 19(1):1044. PubMed ID: 31690270
[TBL] [Abstract][Full Text] [Related]
35. Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential?
Horstmann M; Geiger LM; Vogel U; Schmid H; Hennenlotter J; Kuehs U; Merseburger AS; Kruck S; Stenzl A; Bedke J
World J Urol; 2012 Aug; 30(4):525-31. PubMed ID: 21928123
[TBL] [Abstract][Full Text] [Related]
36. Anxiolytic effect of alamandine in male transgenic rats with low brain angiotensinogen is dependent on activation of MrgD receptors.
Amado Costa L; Oliveira Amaral LB; Mourão FAG; Bader M; Santos RAS; Campagnole-Santos MJ; Kangussu LM
Horm Behav; 2024 Apr; 163():105551. PubMed ID: 38678724
[TBL] [Abstract][Full Text] [Related]
37. Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway.
Yang C; Wu X; Shen Y; Liu C; Kong X; Li P
Eur J Pharmacol; 2020 Sep; 883():173384. PubMed ID: 32707188
[TBL] [Abstract][Full Text] [Related]
38. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of chemokine receptor lymphotactin receptor 1 has prognostic value in clear cell renal cell carcinoma.
Chang X; Cao Y; Fu WL; Tang XF; Wang YL; Lv YF; Guo QN
Mol Genet Genomic Med; 2021 Jan; 9(1):e1551. PubMed ID: 33377624
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
